Silverman, Edwin K. http://orcid.org/0000-0002-3641-3822
Kim, Arthur Y.
Make, Barry J.
Regan, Elizabeth A.
Morrow, Jarrett D.
Hersh, Craig P.
O’Brien, James
Crapo, James D.
Hansel, Nadia N.
Criner, Gerard
Flenaugh, Eric L.
Conrad, Douglas
Casaburi, Richard
Bowler, Russell P.
Hanania, Nicola A.
Barr, R. Graham
Bhatt, Surya P.
Sciurba, Frank C.
Anzueto, Antonio
Han, MeiLan K.
McEvoy, Charlene E.
Comellas, Alejandro P.
DeMeo, Dawn L.
Rosiello, Richard
Curtis, Jeffrey L.
Uchida, Tricia
Wilson, Carla http://orcid.org/0000-0002-1076-5205
O’Rourke, P. Pearl
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (U01 HL089897, U01 HL089856, U01 HL089897, U01 HL089897, U01 HL089856, U01 HL089897)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
COPD Foundation
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
Article History
Received: 27 March 2023
Accepted: 10 October 2023
First Online: 31 October 2023
Competing interests
: In the past three years, Edwin K. Silverman received grant support from Bayer and Northpond Laboratories. In the past three years, Richard Casaburi has received funds for speaker fees from Glaxo Smith Kline and Boehringer Ingelheim, from Inogen and Abbott for Advisory Board service, and from Regeneron and Genentech for consulting services. Jeffrey L. Curtis reports consulting fees from AstraZeneca PLC, CSL Behring LLC, and Novartis Corporation. Surya P. Bhatt has served on advisory boards for Sanofi/Regeneron and Boehringer Ingelheim, and received honorarium for CME from IntegrityCE. In the past three years, Dawn L. DeMeo received grant support from Bayer. In the past three years, Arthur Y. Kim has served on a Data Monitoring Committee for Kintor Pharmaceuticals and received honorarium for CME from Clinical Care Options, LLC. Nicola A. Hanania received honoraria for serving as advisor or consultant for GSK, AstraZeneca, Sanofi, Regeneron, Amgen, Genentech, Verona Pharma, Novartis, and Teva. His institution received research grant support of his behalf from GSK, Genentech, Sanofi, Teva, Novartis, and Astra Zeneca. In the past three years, Craig P. Hersh has received grant support from Bayer, Boehringer-Ingelheim, and Vertex, and consulting fees from Astra Zeneca, Takeda, and Sanofi. In the past three years, Alejandro P. Comellas has served as a paid consultant for GSK, Astra Zeneca, Genentech, Eli Lilly, and as a non-paid consultant for VIDA. In the past three years, MeiLan K. Han reports personal fees from GlaxoSmithKline, Astra Zeneca, Boehringer Ingelheim, Cipla, Chiesi, Novartis, Pulmonx, Teva, Verona, Merck, Mylan, Sanofi, DevPro, Aerogen, Polarian, Regeneron, Amgen, UpToDate, Altesa Biopharma, Medscape, NACE, MDBriefcase, and Integrity. She has received either in kind research support or funds paid to the institution from the NIH, Novartis, Sunovion, Nuvaira, Sanofi, Astra Zeneca, Boehringer Ingelheim, Gala Therapeutics, Biodesix, the COPD Foundation and the American Lung Association. She has participated in Data Safety Monitoring Boards for Novartis and Medtronic with funds paid to the institution. She has received stock options from Meissa Vaccines and Altesa Biopharma. In the past three years Charlene E. McEvoy has received grant funding from GSK and AstraZeneca, consulting fees from Respirtech and GSK.